Literature DB >> 11598029

Phosphorylcholine-dependent cross-reactivity between dental plaque bacteria and oxidized low-density lipoproteins.

H A Schenkein1, C R Berry, D Purkall, J A Burmeister, C N Brooks, J G Tew.   

Abstract

Antibodies reactive with phosphorylcholine (PC) are ubiquitous in human sera, but the antigens stimulating their production and their function are not clear. Previous studies have shown that a significant proportion of dental plaque bacteria contain PC as determined by reactivity with PC-specific mouse myeloma proteins and monoclonal antibodies. Additionally, serum antibody concentrations of immunoglobulin (IgG) G anti-PC are higher in sera of individuals who have experienced periodontal attachment loss than those who are periodontally healthy. These data implicate the oral microflora as a source of antigen-stimulating anti-PC responses. Recent data also indicate that antibodies with specificity for PC are elevated in ApoE-deficient mice, a model for studies of athersclerosis, and that such antibodies bound oxidized low-density lipoproteins (LDL) (oxLDL) in atherosclerotic plaques. These data prompted the hypothesis that human anti-PC could bind to both oral bacteria and human oxLDL, and that these antigens are cross-reactive. We therefore examined the ability of human anti-PC to bind to PC-bearing strains of oral bacteria using enzyme-linked immunosorbent inhibition assays and by assessment of direct binding of affinity-purified human anti-PC to PC-bearing Actinobacillus actinomycetemcomitans. Our results indicated that PC-bearing strains of Streptococcus oralis, Streptococcus sanguis, Haemophilus aphrophilus, Actinomyces naeslundii, Fusobacterium nucleatum, and A. actinomycetemcomitans, as well as a strain of Streptococcus pneumoniae, absorbed up to 80% of anti-PC IgG antibody from human sera. Furthermore, purified anti-PC bound to a PC-bearing strain of A. actinomycetemcomitans but only poorly to a PC-negative strain. OxLDL also absorbed anti-PC from human sera, and oxLDL but not LDL reacted with up to 80% of the anti-PC in human sera. Furthermore, purified anti-PC bound directly to oxLDL but not to LDL. The data indicate that PC-containing antigens on a variety of common oral bacteria are cross-reactive with neoantigens expressed in oxLDL. We propose that PC-bearing dental plaque microorganisms may induce an antibody response to PC that could influence the inflammatory response associated with atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11598029      PMCID: PMC100034          DOI: 10.1128/IAI.69.11.6612-6617.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

1.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

2.  Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.

Authors:  W Palinski; S Hörkkö; E Miller; U P Steinbrecher; H C Powell; L K Curtiss; J L Witztum
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

3.  Detection of the phosphorylcholine epitope in streptococci, Haemophilus and pathogenic Neisseriae by immunoblotting.

Authors:  J Kolberg; E A Høiby; E Jantzen
Journal:  Microb Pathog       Date:  1997-06       Impact factor: 3.738

Review 4.  Epidemiology of periodontal diseases.

Authors:  J D Beck; G D Slade
Journal:  Curr Opin Periodontol       Date:  1996

Review 5.  Cytokines, modified lipoproteins, and arteriosclerosis in diabetes.

Authors:  M F Lopes-Virella; G Virella
Journal:  Diabetes       Date:  1996-07       Impact factor: 9.461

Review 6.  Periodontal disease and cardiovascular disease.

Authors:  J Beck; R Garcia; G Heiss; P S Vokonas; S Offenbacher
Journal:  J Periodontol       Date:  1996-10       Impact factor: 6.993

7.  Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.

Authors:  E Maggi; E Marchesi; V Ravetta; A Martignoni; G Finardi; G Bellomo
Journal:  J Hypertens       Date:  1995-01       Impact factor: 4.844

8.  ELISA of IgG antibody to oxidized low-density lipoprotein: effects of blocking buffer and method of data expression.

Authors:  W Y Craig; S E Poulin; C P Nelson; R F Ritchie
Journal:  Clin Chem       Date:  1994-06       Impact factor: 8.327

9.  Phosphorylcholine-containing antigens in bacteria from the mouth and respiratory tract.

Authors:  S H Gillespie; S Ainscough; A Dickens; J Lewin
Journal:  J Med Microbiol       Date:  1996-01       Impact factor: 2.472

10.  Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM.

Authors:  G Bellomo; E Maggi; M Poli; F G Agosta; P Bollati; G Finardi
Journal:  Diabetes       Date:  1995-01       Impact factor: 9.461

View more
  14 in total

1.  Opsonization of Actinobacillus actinomycetemcomitans by immunoglobulin G antibody reactive with phosphorylcholine.

Authors:  Donald Purkall; John G Tew; Harvey A Schenkein
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

2.  Expression of phosphorylcholine by Histophilus somni induces bovine platelet aggregation.

Authors:  Christopher J Kuckleburg; Shaadi F Elswaifi; Thomas J Inzana; Charles J Czuprynski
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

Review 3.  Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases.

Authors:  Harvey A Schenkein; Bruno G Loos
Journal:  J Clin Periodontol       Date:  2013-04       Impact factor: 8.728

Review 4.  Protective natural autoantibodies to apoptotic cells: evidence of convergent selection of recurrent innate-like clones.

Authors:  Gregg J Silverman
Journal:  Ann N Y Acad Sci       Date:  2015-05-18       Impact factor: 5.691

5.  1,2-Diacylglycerol choline phosphotransferase catalyzes the final step in the unique Treponema denticola phosphatidylcholine biosynthesis pathway.

Authors:  Miguel Ángel Vences-Guzmán; M Paula Goetting-Minesky; Ziqiang Guan; Santiago Castillo-Ramirez; Luz América Córdoba-Castro; Isabel M López-Lara; Otto Geiger; Christian Sohlenkamp; J Christopher Fenno
Journal:  Mol Microbiol       Date:  2017-01-17       Impact factor: 3.501

Review 6.  Microbial modulation of host immunity with the small molecule phosphorylcholine.

Authors:  Sarah E Clark; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2012-12-10       Impact factor: 3.441

7.  Lipoproteins and lipoprotein metabolism in periodontal disease.

Authors:  Rachel Griffiths; Suzanne Barbour
Journal:  Clin Lipidol       Date:  2010-06

Review 8.  Dendritic cells, antibodies reactive with oxLDL, and inflammation.

Authors:  J G Tew; M E El Shikh; R M El Sayed; H A Schenkein
Journal:  J Dent Res       Date:  2011-04-29       Impact factor: 6.116

9.  Periodontitis as a risk factor for cardiovascular disease: the role of anti-phosphorylcholine and anti-cardiolipin antibodies.

Authors:  K Karnoutsos; P Papastergiou; S Stefanidis; A Vakaloudi
Journal:  Hippokratia       Date:  2008-07       Impact factor: 0.471

10.  Genomewide linkage analysis identifies polymorphism in the human interferon-gamma receptor affecting Helicobacter pylori infection.

Authors:  Thorsten Thye; Gerd D Burchard; Manfred Nilius; Bertram Müller-Myhsok; Rolf D Horstmann
Journal:  Am J Hum Genet       Date:  2003-01-06       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.